Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aarti Kawatkar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|July 23, 2019
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane ProteinsAarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, et al.
ACS Chemical Biology|March 21, 2024
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, et al.
ACS Chemical Biology|January 5, 2023
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized HitAarti Kawatkar, Roger A Clark, Lorna Hopcroft, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2015
Identification of azabenzimidazoles as potent JAK1 selective inhibitorsMelissa M Vasbinder, Marat Alimzhanov, Martin Augustin, et al.
Journal of Medicinal Chemistry|June 2, 2018
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase InhibitorsNeil P Grimster, Erica Anderson, Marat Alimzhanov, et al.
Cell Reports. Medicine|March 8, 2023
Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in miceRebecca Jarvis, Shu Fun Josephine Ng, Anna J Nathanson, et al.
Journal of Medicinal Chemistry|December 23, 2025
Optimization and Chemoproteomic Profiling of a Selective, Covalent Bfl-1-Targeting Cellular ToolJ Henry Blackwell, Simon C C Lucas, Giovanni Battocchio, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|July 23, 2019
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane ProteinsAarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson, et al.
ACS Chemical Biology|March 21, 2024
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, et al.
ACS Chemical Biology|January 5, 2023
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized HitAarti Kawatkar, Roger A Clark, Lorna Hopcroft, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2015
Identification of azabenzimidazoles as potent JAK1 selective inhibitorsMelissa M Vasbinder, Marat Alimzhanov, Martin Augustin, et al.
Journal of Medicinal Chemistry|June 2, 2018
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase InhibitorsNeil P Grimster, Erica Anderson, Marat Alimzhanov, et al.
Cell Reports. Medicine|March 8, 2023
Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in miceRebecca Jarvis, Shu Fun Josephine Ng, Anna J Nathanson, et al.
Journal of Medicinal Chemistry|December 23, 2025
Optimization and Chemoproteomic Profiling of a Selective, Covalent Bfl-1-Targeting Cellular ToolJ Henry Blackwell, Simon C C Lucas, Giovanni Battocchio, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Pageof 1